Alexa Catherine Glencer

Title(s)Assistant Professor, Med: Surgery
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Multicenter Interspecialty Consensus on Experimental Oncology Drug-Related Ocular Adverse Event Reporting. JAMA Ophthalmol. 2026 01 01; 144(1):62-68. Pasricha ND, Kim SK, Farooq AV, Lindgren ES, Yan R, Seitzman GD, Chan MF, Shantha JG, Skondra D, Jeng BH, Chamberlain WD, Colby KA, Goldstein DA, Sobrin L, Kim IK, Singh K, Chambers WA, Boyd WM, Silverstein J, Pohlmann PR, Lu J, Glencer AC, Huppert LA, Chien AJ, Rugo HS, Esserman LJ. PMID: 41343206; PMCID: PMC12679423.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    2. Correction: Impact of Pathologic Complete Response on Local-Regional Recurrence and Survival in Patients Undergoing Neoadjuvant Systemic Therapy and Breast-Conserving Surgery. Ann Surg Oncol. 2025 Oct; 32(11):8168. Huynh V, Glencer A, Yi M, Wingate E, Wingate H, Allassan N, Alameddine S, Singh P, Kuerer HM, Hunt KK, Refinetti AP. PMID: 40952542.
      View in: PubMed   Mentions:    Fields:    
    3. Impact of Pathologic Complete Response on Local-Regional Recurrence and Survival in Patients Undergoing Neoadjuvant Systemic Therapy and Breast-Conserving Surgery. Ann Surg Oncol. 2025 Oct; 32(11):8160-8167. Huynh V, Glencer A, Yi M, Wingate E, Wingate H, Allassan N, Alameddine S, Singh P, Kuerer HM, Hunt KK, Refinetti AP. PMID: 40762776.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Intratumoral Injection of mRNA-2752 and Pembrolizumab for High-Risk Ductal Carcinoma In Situ: A Phase 1 Nonrandomized Clinical Trial. JAMA Oncol. 2025 Mar 01; 11(3):288-292. Ramalingam K, Woody R, Glencer A, Schwartz CJ, Mori H, Wong J, Hirst G, Rosenbluth J, Onishi N, Gibbs J, Hylton N, Borowsky AD, Campbell M, Campbell M, Esserman LJ. PMID: 39821301; PMCID: PMC11926637.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    5. Impact of IVF Restriction on Patients With Cancer and Surgeons. JAMA Surg. 2025 Mar 01; 160(3):239-240. Glencer AC, Esserman LJ. PMID: 39630460.
      View in: PubMed   Mentions:    Fields:    
    6. Graft choice in pancreatectomy with vascular resection: equivalent safety in selected patients. J Gastrointest Surg. 2024 11; 28(11):1799-1804. Hoffman D, Ganjouei AA, Hernandez FR, Ifuku K, Miller P, Glencer A, Corvera C, Kirkwood K, Alseidi A, Adam M, Maker A, Hirose K, Hirose R, Nakakura EK. PMID: 39181231.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Magnetic resonance imaging insights from active surveillance of women with ductal carcinoma in situ. NPJ Breast Cancer. 2024 Aug 04; 10(1):71. Greenwood HI, Maldonado Rodas CK, Freimanis RI, Glencer AC, Miller PN, Mukhtar RA, Brabham C, Yau C, Rosenbluth JM, Hirst GL, Campbell MJ, Campbell MJ, Borowsky A, Hylton N, Esserman LJ, Basu A. PMID: 39098868; PMCID: PMC11298531.
      View in: PubMed   Mentions:
    8. The Prevalence of Sentinel Lymph Node Positivity and Implications for the Utility of Frozen Section Diagnosis Following Neoadjuvant Systemic Therapy in Patients with Clinically Node-Negative HER2-Positive or Triple-Negative Breast Cancer. Ann Surg Oncol. 2024 Oct; 31(11):7339-7346. Wanis KN, Goetz L, So A, Glencer AC, Sun SX, Teshome M, Resetkova E, Hwang RF, Hunt KK, Candelaria RP, Huo L, Singh P. PMID: 39048903.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership: Consensus and Opportunities. Ann Surg Oncol. 2024 Oct; 31(11):7326-7334. Glencer AC, Wanis KN, Brown S, Lucci A, Sun SX, Adesoye T, DeSnyder SM, Layman R, Woodward WA, Hunt KK, Teshome M. PMID: 39034365; PMCID: PMC12396853.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. ASO Author Reflections: Management of Inflammatory Breast Cancer: No Role for Surgical De-escalation Yet. Ann Surg Oncol. 2024 Oct; 31(11):7335-7336. Glencer AC, Hunt KK, Teshome M. PMID: 39020114.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Clinical Outcomes for BRCA Pathogenic Variant Carriers With Breast Cancer Undergoing Breast Conservation. JAMA Netw Open. 2024 06 03; 7(6):e2418486. Wanis KN, Kuerer HM, Sun SX, Hunt KK, Glencer AC, Teshome M, Lucci A, Weiser R, Johnson H, Smith BD, Gutierrez AM, Shaitelman SF, Arun BK. PMID: 38916888; PMCID: PMC11200147.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    12. Tumor microenvironmental determinants of high-risk DCIS progression. Res Sq. 2024 May 09. Borowsky A, Glencer A, Ramalingam K, Schindler N, Mori H, Ghule P, Lee K, Nachmanson D, Officer A, Harismendy O, Stein J, Stein G, Evans M, Weaver D, Yau C, Hirst G, Campbell M, Esserman L. PMID: 38766192; PMCID: PMC11100907.
      View in: PubMed   Mentions:
    13. Reply to the Letter from Norman G. Nicolson and Jin He on Our Publication "Neoadjuvant Therapy Versus Upfront Resection for Nonpancreatic Periampullary Adenocarcinoma". Ann Surg Oncol. 2023 02; 30(2):1223-1224. Adam MA, AlMasri S, Glencer A, Zureikat AH. PMID: 36479661; PMCID: PMC11199075.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Identifying Good Candidates for Active Surveillance of Ductal Carcinoma In Situ: Insights from a Large Neoadjuvant Endocrine Therapy Cohort. Cancer Res Commun. 2022 12; 2(12):1579-1589. Glencer AC, Miller PN, Greenwood H, Maldonado Rodas CK, Freimanis R, Basu A, Mukhtar RA, Brabham C, Kim P, Hwang ES, Rosenbluth JM, Hirst GL, Campbell MJ, Campbell MJ, Borowsky AD, Esserman LJ. PMID: 36970720; PMCID: PMC10035518.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    15. Neoadjuvant Therapy Versus Upfront Resection for Nonpancreatic Periampullary Adenocarcinoma. Ann Surg Oncol. 2023 Jan; 30(1):165-174. Adam MA, Glencer A, AlMasri S, Winters S, Bahary N, Singhi A, Lee KK, Paniccia A, Zureikat AH. PMID: 35925536; PMCID: PMC11186695.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    16. ASO Author Reflections: Neoadjuvant Therapy for Nonpancreatic Periampullary Adenocarcinoma. Ann Surg Oncol. 2023 01; 30(1):175-176. Adam MA, Glencer AC, Zureikat AH. PMID: 35882693.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Assessing the role of robotic proctectomy in obese patients: a contemporary NSQIP analysis. J Robot Surg. 2022 Dec; 16(6):1391-1399. Glencer AC, Lin JA, Trang K, Greenberg A, Kirkwood KS, Adam MA, Sarin A. PMID: 35147841; PMCID: PMC9365884.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    18. Unifying the Hepatopancreatobiliary Surgery Fellowship Curriculum via Delphi Consensus. J Am Coll Surg. 2021 09; 233(3):395-414. Park KM, Rashidian N, Mohamedaly S, Brasel KJ, Conroy P, Glencer AC, He J, Passeri MJ, Katariya NN, Alseidi A, TrainHPB research group. PMID: 34166838; PMCID: PMC9308483.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    19. Retransplantation After Living Donor Liver Transplantation: Data from the Adult to Adult Living Donor Liver Transplantation Study. Transplantation. 2021 06 01; 105(6):1297-1302. Braun HJ, Grab JD, Dodge JL, Syed SM, Roll GR, Schwab MP, Liu IH, Glencer AC, Freise CE, Roberts JP, Ascher NL. PMID: 33347261; PMCID: PMC7942712.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    20. Modulation of the immune microenvironment of high-risk ductal carcinoma in situ by intralesional pembrolizumab injection. NPJ Breast Cancer. 2021 May 25; 7(1):59. Glencer AC, Wong JM, Hylton NM, Krings G, McCune E, Rothschild HT, Loveday TA, Alvarado MD, Esserman LJ, Campbell MJ, Campbell MJ. PMID: 34035311; PMCID: PMC8149838.
      View in: PubMed   Mentions: 9  
    21. Live Donor Liver Transplantation in the United States: Impact of Share 35 on Live Donor Utilization. Transplantation. 2021 04 01; 105(4):824-831. Braun HJ, Dodge JL, Grab JD, Schwab ME, Liu IH, Glencer AC, Stock PG, Hirose R, Roberts JP, Ascher NL. PMID: 32433235; PMCID: PMC7980785.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    22. The Evolution of Our Understanding of the Biology of Cancer Is the Key to Avoiding Overdiagnosis and Overtreatment. Cancer Epidemiol Biomarkers Prev. 2020 12; 29(12):2463-2474. Hewitt K, Son J, Glencer A, Borowsky AD, Cooperberg MR, Esserman LJ. PMID: 33033145.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    23. Everolimus and its role in hormone-resistant and trastuzumab-resistant metastatic breast cancer. Future Oncol. 2012 Nov; 8(11):1383-96. Keck S, Glencer AC, Rugo HS. PMID: 23148612.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    24. A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer. Breast Cancer Res Treat. 2012 Jul; 134(1):13-20. Rugo HS, Chien AJ, Franco SX, Stopeck AT, Glencer A, Lahiri S, Arbushites MC, Scott J, Park JW, Hudis C, Nulsen B, Dickler MN. PMID: 22198412; PMCID: PMC3397213.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    Alexa's Networks
    Concepts (107)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (46)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-40-gb10dcd06 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California